FIRST WAVE BIOPHARMA

Live / Registered — Registered (as of 22 Aug 2023)

What this means for you

Registered since 22 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97120355
Registration number
7146620
Mark type
Design + words
Filed
11 Nov 2021
Published for opposition
11 Oct 2022
Registered
22 Aug 2023

Goods and services

  • Class 042 — Scientific and technological services: Biological research and analysis; Industrial research in the field of gastroenterology, gastrohepatology, inflammatory diseases, infectious diseases, and pharmaceuticals for the treatment thereof; Pharmaceutical drug development services; Pharmaceutical research and development; Research and development in the field of pharmaceuticals and pharmaceutical therapies for the treatment of gastrointestinal (GI) diseases, inflammatory diseases, inflammatory bowel diseases (IBD), ulcerative colitis, ulcerative proctitis, Crohn's disease, immune checkpoint inhibitor-associated colitis (ICI-AC), exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis, infectious diseases, and COVID-19 gastrointestinal infections; Research in the field of biopharmaceuticals; Scientific research and development

Owner

Prosecution history

  • 27 Mar 2025 — WITHDRAWAL OF ATTORNEY GRANTED
  • 27 Mar 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
  • 25 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 25 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 25 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 25 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 25 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 22 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 22 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
  • 15 Jul 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 14 Jul 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 06 Jul 2023 — STATEMENT OF USE PROCESSING COMPLETE
  • 06 Jun 2023 — USE AMENDMENT FILED
  • 03 Jul 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 06 Jun 2023 — TEAS STATEMENT OF USE RECEIVED

View this trademark record on Marksy